Quoi de NeuF

Get all the news on neurofibromatosis every month! Here is the December 2021 issue.

Quoi de NeuF – December 2021 (French only)

Download PDF

Here’s what’s in store for you this month in Quoi de NeuF:

  • A biomarker for MPNST: a new strategy for knowing when a plexiform neurofibroma turns into an MPNST
  • A new approach to learning and behavioural difficulties in NF1
  • New clinical study for vestibular schwannoma and NF2 meningiomas
  • Mirdametinib: MEK inhibitor in Phase 2b clinical trial for plexiform neurofibromas